Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy

This study has been completed.
Information provided by (Responsible Party):
DBV Technologies Identifier:
First received: July 24, 2010
Last updated: March 22, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2012
  Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):